ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.750,92
-0,31%
S&P 500
5.308,13
0,09%
US Dollar vs BRL
5,1046
0,00%
Bitcoin
71.337,28
-0,16%
Brent Oil
83,09
-0,53%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Seneca Biopharma Inc (SNCA)

  7. Seneca Biopharma Inc (SNCA) Notícias

SNCA

Seneca Biopharma (SNCA)

Seneca Biopharma Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SNCA
DataHoraFonteTítuloCódigoCompanhia
14/06/202319:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNCASeneca Biopharma Inc
09/06/202310:39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNCASeneca Biopharma Inc
28/04/202307:17Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SNCASeneca Biopharma Inc
27/04/202307:01Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:SNCASeneca Biopharma Inc
21/04/202317:52Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:SNCASeneca Biopharma Inc
21/04/202316:41Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:SNCASeneca Biopharma Inc
21/04/202316:37Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNCASeneca Biopharma Inc
21/04/202316:35Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SNCASeneca Biopharma Inc
22/03/202318:05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SNCASeneca Biopharma Inc
15/02/202318:41Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNCASeneca Biopharma Inc
13/02/202318:35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNCASeneca Biopharma Inc
19/01/202308:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:SNCASeneca Biopharma Inc
04/01/202313:00Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNCASeneca Biopharma Inc
14/11/202210:44Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNCASeneca Biopharma Inc
22/08/202218:29Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:SNCASeneca Biopharma Inc
22/08/202218:22Edgar (US Regulatory)Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)NASDAQ:SNCASeneca Biopharma Inc
22/08/202207:04Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNCASeneca Biopharma Inc
12/08/202217:19Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:SNCASeneca Biopharma Inc
29/07/202218:17Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SNCASeneca Biopharma Inc
18/03/202217:49Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:SNCASeneca Biopharma Inc
18/03/202217:46Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SNCASeneca Biopharma Inc
14/09/202109:01Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:SNCASeneca Biopharma Inc
16/08/202109:02Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:SNCASeneca Biopharma Inc
13/07/202117:16Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:SNCASeneca Biopharma Inc
26/04/202108:00PR Newswire (US)Seneca Biopharma Announces Successful Approval of Merger with Leading Biosciences, Inc.NASDAQ:SNCASeneca Biopharma Inc
20/04/202108:01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SNCASeneca Biopharma Inc
19/04/202108:00GlobeNewswire Inc.Leading BioSciences Provides Update to Seneca Biopharma, Inc. Stockholders on Merger Closing Process Following Virtual Specia...NASDAQ:SNCASeneca Biopharma Inc
13/04/202100:15GlobeNewswire Inc.Leading BioSciences Releases Video Message Encouraging Seneca Biopharma, Inc. Stockholders to Vote at the Virtual Special Mee...NASDAQ:SNCASeneca Biopharma Inc
12/04/202108:00PR Newswire (US)Seneca Biopharma, Inc. Announces (i) Voting Results from the Special Meeting of Stockholders and (ii) New Special Meeting Dat...NASDAQ:SNCASeneca Biopharma Inc
02/04/202112:35GlobeNewswire Inc.Leading BioSciences Releases Video Message Highlighting Compelling Investment Thesis of Proposed Merger with Seneca Biopharma...NASDAQ:SNCASeneca Biopharma Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:SNCA

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
LUPA3
LUPATECH ON
BOV
CASH3
Meliuz S.A ON
BOV
INBR32
Inter &
BOV
GOLL4
GOL PN
BOV
LWSA3
LOCAWEB ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados